Cumberland Low Back Pain Trial

Phase 3

• Conditions: on-specific chronic low back pain; Non-specific chronic low back pain; Alternative and Complementary Medicine - Other anaesthesiology

• Registration Number: ACTRN12605000262606
• Lead Sponsor: niversity of Sydney

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2005-09-02
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 154

Inclusion Criteria

(i)Non-specific low back pain +/- leg pain of at least 3 months duration (ii)Currently seeking care for low back pain (iii) English speaker (iv)Clinical assessment indicates that the subject is suitable for motor control exercise.

Exclusion Criteria

(i)Suspected or confirmed serious spinal pathology (fracture, metastatic, inflammatory or infective diseases of the spine, cauda equina syndrome/widespread neurological disorder).(ii)Suspected or confirmed pregnancy(iii)Are unable to speak English(iv)Nerve root compromise (2 of strength, reflex or sensation affected for same nerve root)(v)Spinal surgery in the past 12 months.(vi)Scheduled for major surgery during treatment or follow-up period (vii)Any of the contraindications to exercise listed on page 42 of the ACSM guidelines (ACSM's Guidelines for Exercise Testing and Prescription, 1995).(viii)Any contraindication to pulsed ultrasound or pulsed shortwave.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Average pain intensity over last week (0-10 scale) [Measured at 2 months];Global perceived effect (Global Perceived Effect Scale)[Measured at 2 months];Patient-generated measure of disability (Patient-Specific Functional Scale)[Measured at 2 months];Recurrence[At 12 months]

Secondary Outcome Measures

Name	Time	Method
(i)Average pain intensity over last week (0-10 scale) [];(ii) Global perceived effect (Global Perceived Effect Scale)[Measured at baseline, 6 months and 12 months.];(iii)Patient- generated measure of disability (Patient-Specific Functional Scale)[Measured at baseline, 6 months and 12 months.];(iv) Condition-specific measure of disability (Roland Morris Disability Questionnaire) [Measured at baseline, 6 months and 12 months.]